Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03369054 · ClinicalTrials.gov registry record · NA
Psychotherapy Trial With Transgender Clients
A NA study of Transgender Persons, M01.777.500, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03369054 is a NA study of Transgender Persons, M01.777.500 that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03369054, a NA study of Transgender Persons, M01.777.500, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Transgender and gender diverse (TGD) individuals are at an increased risk for mental health concerns, including anxiety, trauma-based distress, depression, self-harm, and suicidality. Quantitative and qualitative studies have shown that support appears to mediate mental health concerns, but to date, there have been zero psychotherapy studies focusing on transgender and gender diverse patients. The NIH has noted that TGD patients are considered to be a "health disparities population," indicating that there is considerable research to support prevention and reduction in mental health disparities for this population. There are two aims to the current study-Aim 1: investigate the feasibility of conducting a psychotherapy randomized controlled trial for transgender and gender diverse populations, and Aim 2: longitudinally investigate the impact of minority stress interventions on well-being for transgender and gender diverse patients. First, it is hypothesized that this study will demonstrate feasibility regarding recruitment of transgender and gender diverse patients and that patients from both groups will report treatment acceptability. We also hypothesize that patients will report more acceptability for treatments that are focused on minority stress interventions. It is hypothesized that individuals in both the Minority Stress Treatment (MST) group and Treatment as Usual (TAU) group will both show improvements in well-being, but that the MST group will demonstrate larger effects in outcomes. No known published studies have focused on minority stress psychotherapy interventions for transgender and gender diverse populations. The findings from the proposed study will provide a multitude of information regarding longitudinal psychotherapy interventions focusing on minority stress that will inform future treatment manuals and larger, multi-site studies.
Conditions Studied
Interventions
- BEHAVIORAL Minority Stress Treatment
- BEHAVIORAL Treatment As usual
Study Locations (1)
Wisconsin
- University of Wisconsin Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2019-01-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03369054
The ClinicalTrials.gov registry entry for NCT03369054 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Transgender Persons, M01.777.500 appearing as the primary indexed condition, and to 2 interventions - of which Minority Stress Treatment is the first listed.
NCT03369054 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03369054 about?
NCT03369054 is a clinical study titled "Psychotherapy Trial With Transgender Clients". Transgender and gender diverse (TGD) individuals are at an increased risk for mental health concerns, including anxiety, trauma-based distress, depression, self-harm, and suicidality. Quantitative and qualitative studies have shown that support appears to mediate mental health concerns, but to date,...
What is the current status of trial NCT03369054?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-12-01. Estimated completion is 2019-01-10.
What conditions does trial NCT03369054 study?
This clinical trial studies the following conditions: Transgender Persons, M01.777.500.
What interventions are being tested in trial NCT03369054?
The interventions under investigation include: Minority Stress Treatment (BEHAVIORAL), Treatment As usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT03369054?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03369054 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.